Purchases and Sales Made in Q3 2022 in Xenon Pharmaceuticals Inc. (XENE)
This table provides information about the institutional ownership of Xenon Pharmaceuticals Inc. (XENE) during Q3 2022. The information is specifically focused on institutions that hold shares of Xenon Pharmaceuticals Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2022
Q3 2022
|
Ameriprise Financial Inc
Minneapolis, MN |
SELL
|
- |
-10K- 19.6% |
$309K - $399K
|
41.1K
$1.58M
|
|
|
Nov 14, 2022
Q3 2022
|
Susquehanna Fundamental Investments, LLC
Bala Cynwyd, PA |
SELL
|
- |
-12.5K- 27.31% |
$384K - $496K
|
33.2K
$1.27M
|
|
|
Nov 14, 2022
Q3 2022
|
Engineers Gate Manager LP
New York, NY |
SELL
|
- |
-13K- 57.28% |
$401K - $519K
|
9.72K
$372K
|
|
|
Nov 14, 2022
Q3 2022
|
Boothbay Fund Management, LLC
New York, NY |
SELL
|
- |
-14.5K- 55.05% |
$446K - $577K
|
11.8K
$453K
|
|
|
Nov 14, 2022
Q3 2022
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-19.8K- 15.48% |
$610K - $789K
|
108K
$4.15M
|
|
|
Nov 10, 2022
Q3 2022
|
Cibc World Market Inc.
Toronto, A6 |
SELL
|
- |
-23.6K- 50.31% |
$726K - $939K
|
23.3K
$893K
|
|
|
Nov 15, 2022
Q3 2022
|
State Street Corp
Boston, MA |
SELL
|
- |
-26.9K- 13.61% |
$827K - $1.07M
|
170K
$6.53M
|
|
|
Nov 10, 2022
Q3 2022
|
Exodus Point Capital Management, LP
New York, NY |
SELL
|
- |
-31.3KClosed |
$965K - $1.25M
|
0
$0
|
|
|
Nov 14, 2022
Q3 2022
|
Tri Locum Partners LP
New York, NY |
SELL
|
- |
-32.1K- 19.27% |
$987K - $1.28M
|
134K
$5.15M
|
|
|
Nov 14, 2022
Q3 2022
|
Bridger Management, LLC
New York, NY |
SELL
|
- |
-32.2K- 41.56% |
$990K - $1.28M
|
45.2K
$1.73M
|
|
|
Nov 14, 2022
Q3 2022
|
Cubist Systematic Strategies, LLC
Stamford, CT |
SELL
|
- |
-32.5K- 61.63% |
$1M - $1.29M
|
20.2K
$774K
|
|
|
Nov 14, 2022
Q3 2022
|
Lmr Partners LLP
London, X0 |
SELL
|
- |
-34.3K- 34.3% |
$1.06M - $1.37M
|
65.7K
$2.52M
|
|
|
Nov 14, 2022
Q3 2022
|
Ubs Oconnor LLC
Chicago, IL |
SELL
|
- |
-42K- 43.66% |
$1.29M - $1.67M
|
54.2K
$2.08M
|
|
|
Nov 14, 2022
Q3 2022
|
Janus Henderson Group PLC
London, X0 |
SELL
|
- |
-42.8K- 15.48% |
$1.32M - $1.71M
|
234K
$8.96M
|
|
|
Nov 14, 2022
Q3 2022
|
Dafna Capital Management LLC
Los Angeles, CA |
SELL
|
- |
-63.4K- 14.45% |
$1.95M - $2.52M
|
375K
$14.4M
|
|
|
Nov 08, 2022
Q3 2022
|
Allianz Asset Management Gmb H
Munich, 2M |
SELL
|
- |
-68.6K- 77.43% |
$2.11M - $2.73M
|
20K
$766K
|
|
|
Nov 14, 2022
Q3 2022
|
Moore Capital Management, LP
New York, NY |
SELL
|
- |
-69.1K- 40.15% |
$2.13M - $2.75M
|
103K
$3.95M
|
|
|
Nov 14, 2022
Q3 2022
|
Parkman Healthcare Partners LLC
Stamford, CT |
SELL
|
- |
-72K- 24.43% |
$2.22M - $2.87M
|
223K
$8.53M
|
|
|
Nov 14, 2022
Q3 2022
|
Walleye Capital LLC
Plymouth, MN |
SELL
|
- |
-74K- 45.67% |
$2.28M - $2.94M
|
88K
$3.37M
|
|
|
Nov 14, 2022
Q3 2022
|
Ikarian Capital, LLC
Dallas, TX |
SELL
|
- |
-79K- 32.97% |
$2.43M - $3.14M
|
160K
$6.15M
|
|
|
Nov 10, 2022
Q3 2022
|
Candriam S.C.A.
|
SELL
|
- |
-102K- 11.85% |
$3.15M - $4.07M
|
761K
$29.1M
|
|
|
Nov 14, 2022
Q3 2022
|
Bank Of New York Mellon Corp
New York, NY |
SELL
|
- |
-126K- 22.29% |
$3.87M - $5M
|
438K
$16.8M
|
|
|
Nov 14, 2022
Q3 2022
|
Kynam Capital Management, LP
Princeton, NJ |
SELL
|
- |
-146K- 83.55% |
$4.5M - $5.82M
|
28.8K
$1.1M
|
|
|
Nov 14, 2022
Q3 2022
|
Orbimed Advisors LLC
San Diego, CA |
SELL
|
- |
-192K- 14.44% |
$5.91M - $7.64M
|
1.14M
$43.6M
|
|
|
Nov 14, 2022
Q3 2022
|
Eversept Partners, LP
New York, NY |
SELL
|
- |
-206K- 44.28% |
$6.35M - $8.21M
|
260K
$9.95M
|
|
|
Nov 08, 2023
Q3 2022
|
Eversept Partners, LP
New York, NY |
SELL
|
- |
-206K- 44.28% |
$6.35M - $8.21M
|
260K
$9.95M
|
|
|
Nov 14, 2022
Q3 2022
|
Great Point Partners LLC
Greenwich, CT |
SELL
|
- |
-254K- 23.03% |
$7.83M - $10.1M
|
850K
$32.6M
|
|
|
Nov 15, 2022
Q3 2022
|
Alliancebernstein L.P.
New York, NY |
SELL
|
- |
-287K- 66.8% |
$8.84M - $11.4M
|
143K
$5.47M
|
|
|
Nov 14, 2022
Q3 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-506K- 30.71% |
$15.6M - $20.2M
|
1.14M
$43.8M
|
|
|
Nov 14, 2022
Q3 2022
|
Bvf Inc
San Francisco, CA |
SELL
|
- |
-697K- 43.61% |
$21.5M - $27.7M
|
901K
$34.5M
|
|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-840K- 84.12% |
$25.9M - $33.4M
|
158K
$6.07M
|